8.98
price down icon1.21%   -0.10
after-market Dopo l'orario di chiusura: 8.98
loading

Cogent Biosciences Inc Azioni (COGT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
8.18%
52.70
48.72 50.13 38.87 36.04
Costs And Expenses
7.17%
62.40
58.23 59.58 47.09 43.24
Depreciation and Amortization
0.17%
0.599
0.598 0.581 0.562 0.529
Operating Income/Loss
7.17%
-62.40
-58.23 -59.58 -47.09 -43.24
Nonoperating Income/Loss
5.00%
4.056
3.863 4.198 3.009 4.65
Income/Loss From Continuing Operations Before Tax
7.33%
-58.35
-54.37 -59.58 -44.08 -38.59
Income/Loss From Continuing Operations After Tax
7.33%
-58.35
-54.37 -55.38 -44.08 -38.59
Net Income/Loss
7.33%
-58.35
-54.37 -55.38 -44.08 -38.59
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,878%
94.80
2.3834 86.17 74.75 70.73
Diluted Average Shares
3,878%
94.80
2.3834 86.17 74.75 70.73
Basic Earnings Per Share
1.59%
-0.62
-0.63 -0.64 -0.59 -0.55
Diluted Earnings Per Share
1.59%
-0.62
-0.63 -0.64 -0.59 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
Capitalizzazione:     |  Volume (24 ore):